Febrile neutropenia and role of prophylactic granulocyte colony-stimulating factor in docetaxel and cyclophosphamide chemotherapy for breast cancer

被引:0
|
作者
Yuri Kimura
Shinsuke Sasada
Akiko Emi
Norio Masumoto
Takayuki Kadoya
Morihito Okada
机构
[1] Hiroshima University,Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine
来源
Supportive Care in Cancer | 2021年 / 29卷
关键词
Breast cancer; Primary prophylactic G-CSF; Febrile neutropenia; TC chemotherapy; Relative dose intensity; Hospitalization;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3507 / 3512
页数:5
相关论文
共 50 条
  • [41] Adjuvant Docetaxel and Cyclophosphamide (DC) with Prophylactic Granulocyte Colony-Stimulating Factor (G-CSF) on Days 8 & 12 in Breast Cancer Patients: A Retrospective Analysis
    Yerushalmi, Rinat
    Goldvaser, Hadar
    Sulkes, Aaron
    Ben-Aharon, Irit
    Hendler, Daniel
    Neiman, Victoria
    Ciuraru, Noa Beatrice
    Bonilla, Luisa
    Amit, Limor
    Zer, Alona
    Granot, Tal
    Rizel, Shulamith
    Stemmer, Salomon M.
    PLOS ONE, 2014, 9 (10):
  • [42] TREATMENT OF CYCLIC NEUTROPENIA WITH GRANULOCYTE COLONY-STIMULATING FACTOR
    HAMMOND, WP
    PRICE, TH
    SOUZA, LM
    DALE, DC
    NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (20): : 1306 - 1311
  • [43] Monotherapy with docetaxel and granulocyte colony-stimulating factor in advanced gastric cancer
    Androulakis, N
    Kourousis, C
    Kakolyris, S
    Sarra, E
    Kalbakis, K
    Kalikaki, T
    Kois, S
    Vardakis, N
    Samonis, G
    Georgoulias, V
    ANNALS OF ONCOLOGY, 1998, 9 : 54 - 54
  • [44] GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN NEUTROPENIA
    HOGAN, KR
    PETERS, MD
    DICP-THE ANNALS OF PHARMACOTHERAPY, 1991, 25 (01): : 32 - 35
  • [45] Clinical use of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in neutropenia associated with malignancy
    Lifton, R
    Bennett, JM
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1996, 10 (04) : 825 - &
  • [46] Prophylaxis of Febrile Neutropenia with granulocyte-colony stimulating factor
    Takamatsu, Yasushi
    ANNALS OF ONCOLOGY, 2015, 26 : 59 - 59
  • [47] Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: A systematic review
    Kuderer, Nicole M.
    Dale, David C.
    Crawford, Jeffrey
    Lyman, Gary H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (21) : 3158 - 3167
  • [48] Treatment of advanced breast cancer with docetaxel and gemcitabine with and without human granulocyte colony-stimulating factor
    Kornek, GV
    Haider, K
    Kwasny, W
    Raderer, M
    Schüll, B
    Payrits, T
    Depisch, D
    Kovats, E
    Lang, F
    Scheithauer, W
    CLINICAL CANCER RESEARCH, 2002, 8 (05) : 1051 - 1056
  • [49] Febrile neutropenia with adjuvant docetaxel and cyclophosphamide (TC) chemotherapy for breast cancer.
    Yu, Joanne Linda
    Kurin, Michael
    Pasetka, Mark
    Sridhar, Srikala S.
    Warner, Ellen
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [50] Treatment of advanced breast cancer with vinorelbine and docetaxel with or without human granulocyte colony-stimulating factor
    Kornek, GV
    Ulrich-Pur, H
    Penz, M
    Haider, K
    Kwasny, W
    Depisch, D
    Kovats, E
    Lang, F
    Schneeweiss, B
    Scheithauer, W
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (03) : 621 - 627